SEC Form 4 · accession 0001971702-26-000017
CLOVER HEALTH INVESTMENTS, CORP. /DE · CLOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Conrad Wai
Officer — CEO, Counterpart Health
Period of report
Sep 15, 2026
Accepted (ET)
Sep 16, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001801170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Sep 15, 2026 | S | 300,000 | $4.72 | D | 1,170,056 | I | By Trust. |
| Class A Common Stock | holding | — | — | — | 1,065,699 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $5.06, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.